The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Katherine Wolkoff for The New York Times Supported by By Lisa Miller Lisa Miller interviewed more than two dozen people about the ... to seriously consider taking Zepbound, one of the new ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Both groups followed a reduced-calorie diet and exercise plan ... your healthcare provider for a full list of side effects. Zepbound is a GLP-1 agonist containing tirzepatide, the same active ...

Winfrey has lost her latest weight using a weight-loss drug and with a healthy diet ... People have reduced appetite, and when they do eat, they feel full sooner. Wegovy and Zepbound are approved ...

Instead of following restrictive diets ... Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.